Emerging antimicrobial resistance in the surgical compromised host

Journal of Chemotherapy

Volumn 11, Issue 6, 1999, Pages 518-523

  Wilson, A P R ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Antibiotic resistance; Hand washing; Wound infection

Indexed keywords

CEPHALOSPORIN; METICILLIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; HAND WASHING; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; PROPHYLAXIS; SEPTICEMIA; SURGICAL INFECTION;

EID: 0033389203     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.6.518     Document Type: Conference Paper

References (28)

1. 1 Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493-501.
2. 2 Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50-55.
3. 3 Speller DCE, Johnson AP, James D, Marples RR, Charlett A, George RC. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997; 350: 323-325.
4. 4 Schentag JJ, Hyatt JM, Carr JR, et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium and the importance of antibiotic management and infection control. Clin Infect Dis 1998; 26: 1204-14.
5. 5 Muder RR, Brennan C, Wagener MM, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114: 162-4.
6. 6 Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-23.
7. 7 Haley RW. Methicillin-resistant Staphylococcus aureus: do we just have to live with it? Ann Intern Med 1991; 114: 162-4.
8. 8 Kluytmans JAJW, Mouton JW, Ijzerman EPF, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171: 216-9.
9. 9 Working Party Report. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998; 39: 253-290.
10. 10 Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-3.
11. 11 Moellering RC. The specter of glycopeptide resistance: current trends and future considerations. Am J Med 1998; 104 (5A): 3S-6S.
12. 12 Shannon K, Stapleton P, Xiang X, et al. Extended-spectrum-β-lactamase-producing Klebsiella pneumoniae strain causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol 1998; 36: 3105-10.
13. 13 Pena C, Pujol C, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended spectrum b-lactamases. Antimicrob Agents Chemother 1998; 42: 53-8.
14. 14 Schroder Hansen D, Gottschau A, Jorn Kolmos J. Epidemiology of Klebsiella bacteremia: a case control study using Escherichia coli bacteremia as control. J Hosp Infect 1998; 38: 119-132.
15. 15 Weinbren MJ, Johnson AP, Kaufmann ME, Livermore DM. Acinetobacter spp isolates with reduced susceptibilities to carbapenems in a UK burns unit. J Antimicrob Chemother 1998; 41: 574-6.
16. 16 Afzal-Shah M, Livermore DM. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother 1998; 41: 576-7.
17. 17 Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 1998; 36: 1938-1941.
18. 18 Humphreys H, Towner KJ. Impact of Acinetobacter spp. in intensive care units in Great Britain and Ireland. J Hosp Infect 1997; 37: 281-6.
19. 19 Ayats J, Corbella X, Ardanuy C, et al. Epidemiological significance of cutaneous, pharyngeal and digestive colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 1997; 37: 287-295.
20. 20 Koeleman JGM, Parleviet GA, Dijkshoorn L, Savelkoul PHM, Vandenbroucke-Grauls CMJE. Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J Hosp Infect 1997; 37: 113-123.
21. 21 Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 1998; 26: 1127-1133.
22. 22 Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998; 158: 1127-1132.
23. 23 Bates J. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. J Hosp Infect 1997; 37: 89-101.
24. 24 Bowler ICJW, Storr JA, Davies GJ, Crook DWM. Guidelines for the management of patients colonized or infected with vancomycin-resistant enterococci. J Hosp Infect 1998; 39: 75-82.
25. 25 Byers KE, Durbin LJ, Simonton BM, Anglim AM, Adal KA, Farr BM. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1998; 19: 261-4.
26. 26 Luber AD, Jacobs RA, Jordan M, Guglielmo BJ. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. J Infect Dis 1996; 173: 1292-3.
27. 27 Bradley SJ, Wilson ALT, Allen MC, Sher HA, Goldstone AH, Scott GM. The control of hyperendemic glycopeptide-resistant Enterococcus spp. in a haematology unit by changing antibiotic usage. J Antimicrob Chemother 1999; 43: 261-6.
28. 28 Standing Medical Advisory Committee. Sub-group on antimicrobial resistance. The Path of Least Resistance. London: Department of Health. 1998.